Eli Lilly and Co BDR (LILY34)

65.00 +0.63 (+0.98%)
Closed BRL Disclaimer

LILY34 Financial Summary

Eli Lilly and Company reported earnings results for the fourth quarter and full year ended December 31, 2021. For the fourth quarter, the company reported sales was USD 7,999.9 million compared to USD 7,440 million a year ago. Net income was USD 1,726.1 million compared to USD 2,116.8 million a year ago. Diluted earnings per share from continuing operations was USD 1.9 compared to USD 2.32 a year ago.For the full year, sales was USD 28,318.4 million compared to USD 24,539.8 million a year ago. Net income was USD 5,581.7 million compared to USD 6,193.7 million a year ago. Diluted earnings per share from continuing operations was USD 6.12 compared to USD 6.79 a year ago.
TTM
Trailing Twelve Months
MRQ
Most Recent Quarter
LILY34
Gross margin TTM 75.28%
Operating margin TTM 30.05%
Net Profit margin TTM 20.63%
Return on Investment TTM 30.15%
Total Revenue
Net Income
Title
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Total Revenue 6,941.60 6,488 7,810
Gross Profit 5,362.50 5,057.50 5,737.90
Operating Income 2,037.80 1,744.80 2,663.20
Net Income 1,451.70 952.50 1,902.90
Clear All
0Selected
Please try another search
LILY34
Quick Ratio MRQ 0.61
Current Ratio MRQ 1.13
LT Debt to Equity MRQ -
Total Debt to Equity MRQ 159.3%
Total Assets
Total Liabilities
Title
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Total Assets 47,461.50 47,063.60 46,919.30 48,806
Total Liabilities 37,295.60 38,404.40 37,457.30 39,651.20
Total Equity 10,165.90 8,659.20 9,462
Clear All
0Selected
Please try another search
LILY34
Cash Flow/Share TTM -
Revenue/Share TTM -
Operating Cash Flow 13.96%
Cash
Net Change in Cash
Title
Sep 30, 2022
Jun 30, 2022
Mar 31, 2022
Dec 31, 2021
Cash From Operating Activities 2,184.80 820.70 2,499.20
Cash From Investing Activities -923.40 -463.90 -1,013.80
Cash From Financing Activities -1,263.30 -123.70 -2,878.30
Net Change in Cash -5.50 163.70 -1,359.30
Clear All
0Selected
Please try another search

* In Millions of (except for per share items)

Disclaimer: Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. All CFDs (stocks, indexes, futures), cryptocurrencies, and Forex prices are not provided by exchanges but rather by market makers, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore Fusion Media doesn't bear any responsibility for any trading losses you might incur as a result of using this data.
Fusion Media or anyone involved with Fusion Media will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.